For our final podcast of 2022, Michael and Dominick wrap up by reviewing the year and discuss what we may expect in 2023. Happy New Year to all our listeners!
The Lebenthal Report Episode #82: The Future of the Job Market in 2023
On this week’s Lebenthal Report we welcome Scott Passeser. Scott is one of Long Island’s most respected business leaders and is deeply connected with the Long Island business community.
Scott currently hosts Radio Jobline every Saturday afternoon from 2-3 PM and formerly hosted one of the region’s most watched business television programs, News 12 Long Island’s Jobline from 1989- 2013. Scott has been leading discussions and shaping thinking across the region for decades, while helping Long Islanders find jobs and achieve success in their careers.
Scott has been in the staffing business for over twenty five years. He also has extensive experience in the outplacement and career management fields, and is an expert on the use of social media in job hunting. Scott was so well respected in this field that he was asked by the Long Island Federation of Labor’s Consortium of Worker Education in October of 2001, to run a re-employment program for over 1,000 Long Islanders displaced by the tragic events of 9/11. Scott is a published feature writer on the subject of navigating the job market and was a career columnist for Newsday, Long Island Business News and the Wall Street Journal’s National Business Employment Weekly. Scott was also an Adjunct Professor at Hofstra University and instructed students in job hunting technique and interviewing. Scott connects job hunters with employers in unique ways and, thanks to Long Island News Radio, you can speak to him any time! Join him Saturday afternoons for Radio Jobline on 103.9 FM. (linewsradio.com)
The Lebenthal Report Episode #81: Market Update with Michael Hartzman and Dominick Tavella
On this week of The Lebenthal Report, Michael Hartzman and Dominick Tavella share an update on the markets.
The Lebenthal Report Episode #80: Can This Recent Rally Last? A Discussion with Jake Jolly
This week on The Lebenthal Report Michael and Dominick discuss if the recent rally can last with returning guest Jake Jolly. Jake Jolly, CFA is a Senior Investment Strategist at BNY Mellon Investment Management. In this role, he is a primary contact for the firm’s largest and most complex clients, providing ongoing updates on the market outlook, investment philosophy, process, and performance across asset classes. He produces rigorously researched market commentary and investment content to shape investment strategy decisions. Jake collaborates with portfolio managers and researchers across BNY Mellon Investment Management’s investment firms to provide a vital link between investment, product, and distribution teams.
The Lebenthal Report Episode #79: Making Sense of the Recent CPI Data
This week on The Lebenthal Report we welcome back returning guest John Eade. John Eade is CEO and President of Argus Research Corporation. He has been with Argus since 1989 and has worked as an analyst, director of research, market strategist, and director of portfolio strategies at the firm. He has an MBA in finance from New York University's Stern School of Business and a Bachelor's degree in journalism from Northwestern University's Medill School of Journalism. He has been involved with Argus's new product development team, which has kept the company at the forefront of the independent research industry. He is a founder and board member of the Investorside Research Association, an industry trade organization. He is also a member of the New York Society of Security Analysts and the CFA Institute. He has been interviewed and quoted extensively in The New York Times, The Wall Street Journal, Forbes, Time, Fortune and Money magazines and has been a frequent guest on Fox Business News, CNBC, CNN, CBS News, ABC News and the Bloomberg Radio and Television networks.
The Lebenthal Report Episode #78: James Geraghty, Author of Inside the Orphan Drug Revolution
This week on The Lebenthal Report we welcome James Geraghty. James Geraghty has been a director of eight NASDAQ-listed biotech companies and chair of five. He’s worked on orphan drugs for over forty years—as a strategy consultant, a CEO, a leader of pioneering international operations at Genzyme, and a venture entrepreneur. As a biotechnology executive, he has been a passionate participant in the orphan drug revolution since its inception. His book, Inside the Orphan Drug Revolution: The Promise of Patient-Centered Biotechnology, is in part a history, with eye-witness accounts of advances as they occurred and portraits of the pioneering scientists and physicians, tireless activists, and visionary business leaders who made the revolution happen.
The Lebenthal Report Episode #77: Market Update with Jim Kelleher
On this week's episode of The Lebenthal Report, Dominick Tavella and Michael Hartzman share an update on the markets with returning guest Jim Kelleher.
Stream Michael's Interview from Radio Jobline
You can now stream Scott Passeser’s interview with Michael from his LI News Radio show, Radio Jobline.